Prevention New Translational Research Collaboration in Infection & AMR is now launched
The 蓝莓视频 Imperial BRC, as the Host Organisation, has successfully launched the 7th 蓝莓视频 Translational Research Collaboration (TRC), a new UK-wide initiative designed to tackle the challenges of infection and antimicrobial resistance (AMR). This TRC is chaired by Prof Graham Cooke, the theme lead of our BRC Infection & AMR theme, and co-chaired by Prof Sarah Walker from the 蓝莓视频 Oxford BRC.
Why this TRC
The development of new infection interventions demands a strong translational pipeline that spans multiple diseases and delivers evidence quickly enough to inform real-world use. The COVID-19 pandemic underscored the complexity of tackling infection and antimicrobial resistance (AMR), highlighting the need for coordinated research infrastructure and collaborative effort. From accelerating vaccine and treatment development to enabling rapid diagnostic innovation and optimising clinical practice, a unified approach is essential to meet these evolving global health challenges.
Aims of the TRC
This TRC will lead a national effort to advance research across vaccines, diagnostics and treatment strategies for infectious diseases and AMR. By uniting expertise from 17 TRC research members, the TRC aims to strengthen collaboration with academic, industry and charity partners, while building a coordinated infrastructure to support the UK鈥檚 response to current and emerging infection threats, including early-phase clinical trials.
In addition to its scientific mission, the TRC will prioritise meaningful patient and public involvement, ensuring diverse voices inform research priorities. It will also invest in nurturing early-career researchers and fostering talent, particularly from underserved communities, helping to build a sustainable and inclusive future workforce in infection science.
Prof Cooke said, “We will reinvigorate and unify, for the first time, the broad expertise in infection and AMR across the experimental medicine and early phase research infrastructure in the UK into a cohesive, dynamic partnership. This will facilitate industry engagement and further collaboration, and will contribute towards increasing the UK鈥檚 capacity and capability in this critical research field.鈥�
More details can be found here-
